No Increased Risk for Single-Stage Implant Breast Reconstruction
(HealthDay News) — Single-stage implant breast reconstruction is a less invasive procedure that may offer good aesthetic outcome with no additional oncologic risk in selected patients, according to research published in the August issue of Plastic and Reconstructive Surgery.
Jose Rodriguez-Feliz, MD, of Emory University, and Mark A. Codner, MD, of Mark Codner Plastic Surgery – both in Atlanta, describe surgical experience for 27 single-stage breast implant reconstructions performed by Codner. The authors also conducted a literature review to further examine patient selection, implant selection, and mastectomy incision choices.
The researchers found that, for the 27 single-stage breast implant reconstructions, the average mastectomy weight was 343.82g, and the average implant volume was 367cc. For implant selection, shaped implants were the most common choice. In all breast reconstructions, acellular dermal matrix was used. Complications included erythema requiring intravenous antibiotic therapy, in three patients; exposed/infected implants (salvaged using a published sequential irrigation protocol), in two patients; and skin ischemia caused by methylene blue, seroma, unilateral partial nipple necrosis, and mastectomy skin necrosis, each in one patient.
"Selected patients will benefit from a one-and-done breast implant reconstruction with no additional oncologic risk," the authors write. "Surgeons must embrace the change and provide their patients with a procedure that will offer the best aesthetic outcomes."
One author disclosed financial ties to biomedical and medical publishing companies.